InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,672.00
(
0.18%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.57
(
-1.65%
)
Bitcoin
60,452.56
(
-4.12%
)
Post# of 3707
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

murocman

Send PM Follow Ignore
Followers 12
Posts 917
Boards Moderated 0
Alias Born 08/01/2006

murocman

Re: None

Sunday, 08/16/2015 10:32:44 PM

Sunday, August 16, 2015 10:32:44 PM

Post# of 3707
I think PTN wins regardless of Addyia approval or denial


If Sprout's drug is approved, PTN will benefit from the buzz and being the only public company n the sector. If it get's disapproved, they have the market all to themselves with a much more attractive product. Seems like it should do well either way.

GLTA,

Murocman
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PTN News
More PTN News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!